A multicenter comparison of PD-L1 protein and mRNA expression in urothelial bladder cancer by immunohistochemistry and RT-qPCR (Checkpoint-Typer(C)): A round robin test by the BRIDGE-Consortium Germany (2018) Eckstein M, Wirtz R, Pfannstil C, Wach S, Stoehr R, Breyer J, Erlmeier F, et al. Conference contribution A randomised phase II study of Nivolumab plus Ipilimumab versus Standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST) (2018) Ahrens M, Scheich S, Goekbuget N, Boleti E, Gruenwald V, Escudier B, Goebell P, et al. Conference contribution Salvage external beam radiation therapy of biochemical relapse after radical prostatectomy: Results and potential role of PET/CT (2018) Rutzner S, Lubgan D, Wullich B, Kuehn R, Kuwert T, Fietkau R Conference contribution P4HA1: A single-gene surrogate of hypoxia signatures in oral squamous cell carcinoma patients (2018) Kappler M, Kotrba J, Kaune T, Bache M, Rot S, Bethmann D, Wichmann H, et al. Conference contribution Effectiveness and safety of pazopanib (PAZO) and everolimus (EVE) in a changing treatment (Tx) landscape: Interim results of the non-interventional study PAZOREAL (2018) Boegemann M, Bedke J, Schostak M, Welslau M, Hering-Schubert C, Wolf T, Schleicher J, et al. Conference contribution ATLAS: a phase 2, open-label study of rucaparib in patients with locally advanced (unresectable) or metastatic urothelial carcinoma (2018) Feyerabend S, Boegemann M, Goebell P, Stoeckle M, Nepert D, Wride K, Thomas D, et al. Conference contribution SUNNIFORECAST - A phase II study of Nivolumab in combination with Ipilimumab versus Standard of care in advanced or metastatic non-clear cell renal cell carcinoma (2018) Scheich S, Ahrens M, Goekbuget N, Boleti E, Burkholder , Escudier BJ, Goebell P, et al. Conference contribution Complications of tracheoesophageal shunts after laryngectomy (2018) Scherl C, Kauffels J, Schützenberger A, Döllinger M, Bohr C, Koch M, Traxdorf M, Iro H Conference contribution Final analysis of time to subsequent disease progression/death in patients with metastatic enteropancreatic neuroendocrine tumours progressing under placebo and switched to lanreotide Autogel/depot 120mg in the CLARINET open-label extension (2018) Pavel ME, Cwikla J, Wolin E, Phan A, Raderer M, Sedlackova E, Cadiot G, et al. Conference contribution The role of donor clonal hematopoiesis in allogeneic hematopoietic stem cell transplantation (2018) Frick M, Chan W, Arends CM, Hablesreiter R, Halik A, Blau O, Heuser M, et al. Conference contribution